InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: trading.jeff post# 37856

Thursday, 12/08/2016 6:56:43 PM

Thursday, December 08, 2016 6:56:43 PM

Post# of 48316
Agreed. Btw they said they expect to enroll about 60 patients for the registration trial, on par with the numbers CAR-T firms are enrolling. An Australian subsidiary would not only speed up enrollment but also open the doors to a big foreign market after approval, esp. for melanoma. Good progress being made at OncoSec IMO. I think Sharron Gargosky had something to do with this. She's originally from Australia.